ABT
Stock Details
ABT is Abbott Laboratories's stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 106.32$. Average daily volumn in 3 months 5M. Market cap 168.34B
Stock symbol : ABT. Exchange : NYSE. Currency : USD Lastest price : 96.86$. Total volume : 3.46M. Market state POST Click reload if you want to check the lastest price on market!!!
Abbott Laboratories (ABT)
Last Price
96.86$Change
-1.47Volume
3.46M
| Previous Close | 98.33 |
| Open | 98.61 |
| Day Range | 96.84-99.31 |
| Bid | 97.61 x 1.2k |
| Ask | 98.87 x 900 |
| Volume | 3.46M |
| Average Volume | 5M |
| Market Cap | 168.34B |
| Beta | 0.67 |
| 52 Week Range | 93.25-124.36 |
| Trailing P/E | 24.65 |
| Foward P/E | 20.01 |
| Dividend (Yield %) | 2.08% |
| Ex-Dividend Date | 2023-04-13 |
Financial Details
Organization
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecologi... cal disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
Market Cap:
168.34BRevenue:
43.65BTotal Assets:
74.44BTotal Cash:
9.88B
News about "Abbott Laboratories"
Here's Why You Should Retain Abbott (ABT) Stock for Now
Source from : Yahoo Finance - 10 hours ago
Abbott Laboratories ABT is well-poised for growth in the coming quarters, courtesy of its continued growth in the core Diagnostics arm. Solid fourth-quarter 2022 performance buoys optimism. However, ...See details»
A history of Abbott and AbbVie
Source from : pharmaphorum - 2 days ago
This month, we explore the 125-year-old history of Abbott Laboratories and its most significant milestone to date – the creation of its own independent company, AbbVie. In 1888, a 30-year-old ...See details»
Abbott Laboratories: A Dividend King At A Discount
Source from : Seeking Alpha - 2 days ago
Abbott comes with a decent dividend yield and sustainable dividend growth backed by a wide-moat business model. Read why ABT stock is a Buy.See details»
Abbott Labs: Steadily Getting Back To Normal
Source from : Seeking Alpha - 2 days ago
Abbott has had a crazy couple of years, with a formula recall and a COVID testing boom. Find out why I rate ABT stock a hold.See details»
Abbott Laboratories (ABT) Shares Up Despite Recent Market Volatility
Source from : newsheater - 1 days ago
Abbott Laboratories (NYSE: ABT)’s stock price has increased by 0.89 compared to its previous closing price of 97.01. However, the company has seen a fall of -0.33% in its stock price over the last ...See details»
Peering Into Abbott Laboratories's Recent Short Interest
Source from : Benzinga on MSN - 6 days ago
Abbott Laboratories's (NYSE:ABT) short percent of float has risen 5.13% since its last report. The company recently reported that it has 13.93 million shares sold short, which is 0.82% of all regular ...See details»
Abbott Laboratories (ABT): A Fresh Data-Based Analysis
Source from : stocksregister - 5 days ago
Abbott Laboratories (NYSE:ABT) price on Friday, March 17, fall -2.04% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $97.01. A look at the stock’s price ...See details»
Abbott Laboratories stock falls Wednesday, underperforms market
Source from : MarketWatch - 7 days ago
Shares of Abbott Laboratories dropped 0.76% to $97.80 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the ...See details»
Abbott Laboratories (NYSE:ABT) Is Down -10.24% Year To Date; Analysts Say It Will Rally
Source from : stocksregister - 7 days ago
Abbott Laboratories (NYSE:ABT) price closed higher on Tuesday, March 14, jumping 0.37% above its previous close. A look at the daily price movement shows that the last close reads $98.19, with ...See details»
Abbott faces SEC investigation over infant formula debacle
Source from : CBS News - 1 month ago
Abbott Laboratories is facing investigations by the Securities and Exchange Commission and the Federal Trade Commission (FTC) in connection with its formula business, the company revealed in a ...See details»
Abbott (ABT) to Pair CGM Sensors & AID System on FDA Clearance
Source from : Zacks.com on MSN - 9 days ago
Abbott Laboratories ABT recently announced that its modified continuous glucose monitoring (CGM) system sensors, FreeStyle Libre 2 and FreeStyle Libre 3, have received FDA clearance for integration ...See details»
Abbott Laboratories (ABT) Stock: A Study of the Market Performance
Source from : newsheater - 8 days ago
The stock of Abbott Laboratories (ABT) has seen a -4.44% decrease in the past week, with a -9.14% drop in the past month, and a -8.16% decrease in the past quarter. The volatility ratio for the week ...See details»
U.S. FDA clears Abbott's blood test for concussions
Source from : Reuters - 15 days ago
Abbott Laboratories logo is displayed on a screen at the New York Stock Exchange (NYSE) in New York City, U.S., October 18, 2021. REUTERS/Brendan McDermid March 7 (Reuters) - The U.S. Food and ...See details»
Client Profile: Abbott Laboratories
Source from : OpenSecrets.org - 1 month ago
Abbott Laboratories $3,960,000 Jennifer Barblan No Revolving Door Profiles Non Former Members of Congress Abbott Laboratories $3,960,000 P Claude Burcky Revolving Door Profiles Non Former Members of ...See details»